Top

Journal of Neurology

Published in:

Open Access 09-11-2023 | Migraine | Letter to the Editors

Susac syndrome in a patient with migraine shortly after COVID-19 booster vaccination: more than a temporal relation?

Authors: Stergios Tsitos, Adrian Danek, Andreas Straube

Published in: Journal of Neurology | Issue 1/2024

Excerpt

Dear editors, …

Dörr J, Krautwald S, Wildemann B, Jarius S, Ringelstein M, Duning T, Aktas O, Ringelstein EB, Paul F, Kleffner I (2013) Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol 9(6):307–316. https://doi.org/10.1038/nrneurol.2013.82. (Epub 2013 Apr 30 PMID: 23628737)CrossRefPubMed

Pereira S, Vieira B, Maio T, Moreira J, Sampaio F (2020) Susac’s syndrome: an updated review. Neuroophthalmology 44(6):355–360. https://doi.org/10.1080/01658107.2020.1748062.PMID:33408428;PMCID:PMC7746245CrossRefPubMedPubMedCentral

Gross CC, Meyer C, Bhatia U, Yshii L, Kleffner I, Bauer J, Tröscher AR, Schulte-Mecklenbeck A, Herich S, Schneider-Hohendorf T, Plate H, Kuhlmann T, Schwaninger M, Brück W, Pawlitzki M, Laplaud DA, Loussouarn D, Parratt J, Barnett M, Buckland ME, Hardy TA, Reddel SW, Ringelstein M, Dörr J, Wildemann B, Kraemer M, Lassmann H, Höftberger R, Beltrán E, Dornmair K, Schwab N, Klotz L, Meuth SG, Martin-Blondel G, Wiendl H, Liblau R (2019) CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome. Nat Commun 10(1):5779. https://doi.org/10.1038/s41467-019-13593-5.PMID:31852955;PMCID:PMC6920411CrossRefPubMedPubMedCentral

Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA (2019) Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 18(8):795–804. https://doi.org/10.1016/S1474-4422(19)30185-1. (Epub 2019 May 31. PMID: 31160203; PMCID: PMC7164539)CrossRefPubMedPubMedCentral

Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annu Rev Physiol 75:365–391. https://doi.org/10.1146/annurev-physiol-030212-183717. (Epub 2012 Nov 26 PMID: 23190076)CrossRefPubMed

Karatas H, Erdener SE, Gursoy-Ozdemir Y, Lule S, Eren-Koçak E, Sen ZD, Dalkara T (2013) Spreading depression triggers headache by activating neuronal Panx1 channels. Science 339(6123):1092–1095. https://doi.org/10.1126/science.1231897. (Erratum.In:Science.2015Oct2;350(6256):aad5166.Erratumin:Science.2015Nov20;350(6263):921 PMID: 23449592)CrossRefPubMed

Kleffner I, Dörr J, Ringelstein M, Gross CC, Böckenfeld Y, Schwindt W, Sundermann B, Lohmann H, Wersching H, Promesberger J, von Königsmarck N, Alex A, Guthoff R, Frijns CJ, Kappelle LJ, Jarius S, Wildemann B, Aktas O, Paul F, Wiendl H, Duning T, European Susac Consortium (EuSaC) (2016) Diagnostic criteria for Susac syndrome. J Neurol Neurosurg Psychiatry 87(12):1287–1295. https://doi.org/10.1136/jnnp-2016-314295. (Epub 2016 Oct 25. PMID: 28103199)CrossRefPubMed

Novais FO, Carvalho AM, Clark ML, Carvalho LP, Beiting DP, Brodsky IE et al (2017) CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production. PLoS Pathog 13(2):e1006196. https://doi.org/10.1371/journal.ppat.1006196CrossRefPubMedPubMedCentral

Bolay H, Karadas Ö, Oztürk B, Sonkaya R, Tasdelen B, Bulut TDS, Gülbahar Ö, Özge A, Baykan B (2021) HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism. J Headache Pain 22(1):94. https://doi.org/10.1186/s10194-021-01306-7. (PMID: 34384355; PMCID: PMC8358545)CrossRefPubMedPubMedCentral

10.

Coutre SE, Barnett C, Osiyemi O, Hoda D, Ramgopal M, Fort AC, Qaqish R, Hu Y, Ninomoto J, Alami NN, Styles L, Treon SP (2022) Ibrutinib for hospitalized adults with severe coronavirus disease 2019 infection: results of the randomized, double-blind, placebo-controlled iNSPIRE study. Open Forum Infect Dis 9(5):ofac104. https://doi.org/10.1093/ofid/ofac104CrossRefPubMedPubMedCentral

11.

Ito M, Shichita T, Okada M, Komine R, Noguchi Y, Yoshimura A, Morita R (2015) Bruton’s tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury. Nat Commun 10(6):7360. https://doi.org/10.1038/ncomms8360. (PMID: 26059659; PMCID: PMC4490404)CrossRef

Title: Susac syndrome in a patient with migraine shortly after COVID-19 booster vaccination: more than a temporal relation?
Authors: Stergios Tsitos
Adrian Danek
Andreas Straube
Publication date: 09-11-2023
Publisher: Springer Berlin Heidelberg
Keywords: Migraine
Headache
Vaccination
Aura
SARS-CoV-2
Published in: Journal of Neurology / Issue 1/2024
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-023-12088-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Susac syndrome in a patient with migraine shortly after COVID-19 booster vaccination: more than a temporal relation?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose

Pathological findings in autoimmune encephalitis autopsy specimens from cases of suspected prion disease

Clinical and genetic analyses of a Swedish patient series diagnosed with ataxia

Neuroimaging determinants of cognitive impairment in the memory clinic: how important is the vascular burden?

eHealth tools to assess the neurological function for research, in absence of the neurologist – a systematic review, part I (software)

Informed consent practices for acute stroke therapy: principles, challenges and emerging opportunities